Ocrelizumab concentration and antidrug antibodies are associated with B-cell count in multiple sclerosis.

Autor: Toorop AA; Department of Neurology, MS Center Amsterdam, Amsterdam UMC Location VUMC, Amsterdam, The Netherlands a.toorop@amsterdamumc.nl., Hogenboom L; Department of Neurology, MS Center Amsterdam, Amsterdam UMC Location VUMC, Amsterdam, The Netherlands., Bloem K; Biologics Laboratory, Sanquin Diagnostic Services, Amsterdam, The Netherlands., Kocyigit M; Department of Neurology, MS Center Amsterdam, Amsterdam UMC Location VUMC, Amsterdam, The Netherlands., Commandeur NWM; Biologics Laboratory, Sanquin Diagnostic Services, Amsterdam, The Netherlands., Wijnants A; Biologics Laboratory, Sanquin Diagnostic Services, Amsterdam, The Netherlands., Lissenberg-Witte BI; Department of Epidemiology and Data Science, Vrije Universiteit Amsterdam, Amsterdam, The Netherlands., Strijbis EMM; Department of Neurology, MS Center Amsterdam, Amsterdam UMC Location VUMC, Amsterdam, The Netherlands., Uitdehaag BMJ; Department of Neurology, MS Center Amsterdam, Amsterdam UMC Location VUMC, Amsterdam, The Netherlands., Rispens T; Biologics Laboratory, Sanquin Diagnostic Services, Amsterdam, The Netherlands.; Landsteiner Laboratory, Amsterdam UMC Location AMC, Amsterdam, The Netherlands., Killestein J; Department of Neurology, MS Center Amsterdam, Amsterdam UMC Location VUMC, Amsterdam, The Netherlands., van Kempen ZLE; Department of Neurology, MS Center Amsterdam, Amsterdam UMC Location VUMC, Amsterdam, The Netherlands.

Publikováno v: Journal of neurology, neurosurgery, and psychiatry [J Neurol Neurosurg Psychiatry] 2023 Jun; Vol. 94 (6), pp. 487-493. Date of Electronic Publication: 2023 Jan 24.